Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-10
2009-08-11
Weddington, Kevin E (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S236200, C514S415000, C514S652000, C514S682000, C514S714000, C514S724000, C514S743000
Reexamination Certificate
active
07572782
ABSTRACT:
A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide (“DMSO”); a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to effectively stimulate bone regeneration and increase osteoblastic activity in a patient.
REFERENCES:
patent: 4451480 (1984-05-01), DeVillez
patent: 4591602 (1986-05-01), DeVillez
patent: 4983637 (1991-01-01), Herman
patent: 5086076 (1992-02-01), Herman
patent: 5126376 (1992-06-01), Herman
patent: 5190977 (1993-03-01), Herman
patent: 5190979 (1993-03-01), Herman
patent: 5260342 (1993-11-01), Herman
patent: 5270344 (1993-12-01), Herman
patent: 5364879 (1994-11-01), Herman
patent: 6790463 (2004-09-01), Hofmann et al.
patent: 6884797 (2005-04-01), Hofmann
patent: WO 02/078622 (2002-10-01), None
patent: WO 03/065996 (2003-08-01), None
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration from the PCT dated May 5, 2006.
Beck-Coon, R.J., et al.; “An In Vivo of the Use of a Nonresorbable Ceramic Hydroxyapatite as an Alloplastic Graft Material in Periapical Surgery”; Oral Surg Med Oral Pathol, vol. 71(4), pp. 483-488, 1991.
Chakraborti, T., et al.; “Oxidant, Mitochondria and Calcium: an Overview”; Cell Signal; vol. 11(2), pp. 77-85, 1999.
Granchi, D., et al.; “Endodontic Cements induce Alterations in the Cell Cycle of an In Vitro Cultured Osteoblasts”; Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol. 79(3), pp. 359-366, 1995.
Plachot, J.J., et al.; “Mitochondrial Calcium and Bone Mineralization in the Rat Fetus”; Bone Miner, vol. 1(2), pp. 157-166, 1986.
World Health Organization, The Burden of Musculoskeletal Conditions at the Start of the New Millenium, Global Burden of Diseases 2000 Study, 2000. Who Technical Report, Series 919, published 2003.
Jackson Walker L.L.P.
Torquin, LLC
Weddington Kevin E
LandOfFree
Use of targeted oxidative therapeutic formulation in bone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of targeted oxidative therapeutic formulation in bone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of targeted oxidative therapeutic formulation in bone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4117022